JPRN-UMIN000021768已完成4 期
A multicenter open-label randomized controlled trial comparing interferon-nucleoside/nucleotide analogues add-on therapy with interferon-nucleoside/nucleotide analogues sequential therapy for chronic hepatitis B. - Interferon-nucleoside/nucleotide analogues add-on and sequential therapy for chronic hepatitis B: a randomized controlled trial
Department of Gastroenterology,Saitama Medical Center, Jichi Medical University0 个研究点目标入组 60 人开始时间: 2016年4月6日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)The patients who are prescribed with Sho-saiko-toh. (2)The patients who had or have interstitial pneumonia. (3)The patients with autoimmune hepatitis. (4)The patients who have an allergy against interferon and other medications in the study. (5)The patients who have allergy against vaccine or other biologics. (6)The patients with a severe mental disease such as depression, a suicide consideration, or suicide project, or the past history of such conditions. (7)The patients with liver cirrhosis or severe hepatic diseases. (8)The patients with untreated hepatic cancers. (9)The patients who were judged inappropriate for the study by the doctor.
研究者
相似试验
未知
4 期
A multicenter open-label randomized controlled trial comparing interferon-entecavir sequential therapy with interferon monotherapy for chronic hepatitis Bchronic hepatitis BJPRN-UMIN000000595Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences170
已完成
4 期
A multicenter open-label randomized controlled trial comparing continuing lamivudine treatment with switching from lamivudine to entecavir treatment for the patients with chronic hepatitis B or cirrhosis receiving lamivudine administration without lamivudine-resistant YMDD mutant virus.Chronic hepatitis B or cirrhosisJPRN-UMIN000000601Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences120
尚未招募
不适用
A randomized multicenter open-label controlled trial to show that mucous fistula refeeding reduces the time from enterostomy closure to full enteral feeds (MUCous FIstula REfeeding (*MUC-FIRE*) trial)Enterostomymucous fistula refeedingNL-OMON56093niversity of Leipzig, Department of Pediatric Surgery16
尚未招募
Unknown
A multi-center open-label randomized controlled trial to evaluate the efficacy of the Mantis Clip for defect closure following colorectal endoscopic submucosal dissectioJPRN-UMIN000054070The Jikei University School of Medicine250
招募中
不适用
Open-label, multicenter, randomized controlled trials, for comparing remission induction rate of a dose-escalation therapy of methotrexate and an additional combination therapy with bucillamine for naive patients to over 8 mg/weekly of methotrexate.Rheumatoid arthritisJPRN-UMIN000007404KONAMON Study Group90